ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1485

Patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS) Present Esophageal and Anorectal Involvement: Data From a Single Centre

Gemma Lepri1, Silvia Bellando-Randone2, Serena Guiducci3, Iacopo Giani4, Cosimo Bruni5, Giulia Carnesecchi2, Jelena Blagojevic2, Alessandra Radicati2, Filippo Pucciani6 and Marco Matucci Cerinic2, 1Department of Internal Medicine, Section of Rheumatology, Transition Clinic, University of Florence, Florence, Italy, 2Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy, 3Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, 4General Surgery, ASL 8, Arezzo, Italy, Arezzo, Italy, 5Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 6General and Urgency Surgery, University of Florence, Florence, Italy, Florence, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic Sclerosis (SSc) affects gastrointestinal tract in more than 80% of patients. Esophageal involvement is the most common manifestation with a prevalence ranging between 50-90%, followed by anorectal involvement (prevalence of 50-70%) that had a high impact on patients quality of life. Objectives of the study: evaluation of esophageal and anorectal involvement and of their correlations in very early SSc patients.

Methods: 56 VEDOSS patients (55 females), mean age 49,2 ± 14, were evaluated with esophageal and anorectal manometry. The demographic data, esophageal and anorectal symptoms (dysphagia, typical GERD symptoms and fecal incontinence and constipation), Raynaud phenomenon (presence/absence, duration) autoantibodies profile (anticentromere antibodies [ACA], antinuclear antibodies [ANA], anti-Scl70 [Scl70]), videocapillaroscopy patterns (Normal, Early, Active, Late), puffy fingers, digital ulcers were recorded for all patients.

Results:

Esophageal body dysmotility (absence of peristalsis or abnormal mean pressure of peristalsis) was present in 49 patients (94,2%) and it was associated with an hypotensive lower esophageal sphincter (LES) in 26 (53,1%). Anorectal manometry was abnormal in 85% of patients and in all these patients an esophageal involvement was found (absence of peristalsis in 29% of patients and an abnormal peristalsis in 67,7% of patients). Esophageal symptoms were present in 26 patients (50%). 22 patients (42,3%) showed puffy fingers that were associated with a smaller area of LES (p-value: 0,011). Only five patients (12,5%) complained anorectal symptoms. In 4 patients esophageal manometry was not performed because of scarce tolerance of the procedure and in 16 patients anorectal manometry was not performed for the same reason.

Conclusion: In VEDOSS patients esophageal and anorectal disorders are frequently detected even in asymptomatic patients. Our data showed that VEDOSS is characterized by simultaneous esophageal and anorectal involvement. Esophageal disorders seem to correlate with the presence of puffy fingers.


Disclosure:

G. Lepri,
None;

S. Bellando-Randone,
None;

S. Guiducci,
None;

I. Giani,
None;

C. Bruni,
None;

G. Carnesecchi,
None;

J. Blagojevic,
None;

A. Radicati,
None;

F. Pucciani,
None;

M. Matucci Cerinic,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-very-early-diagnosis-of-systemic-sclerosis-vedoss-present-esophageal-and-anorectal-involvement-data-from-a-single-centre/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology